All-Cause Mortality Risk in Australian Women with Impaired Fasting Glucose and Diabetes

被引:8
|
作者
de Abreu, Lelia L. F. [1 ]
Holloway, Kara L. [1 ]
Mohebbi, Mohammadreza [1 ]
Sajjad, Muhammad A. [1 ]
Kotowicz, Mark A. [1 ,2 ,3 ]
Pasco, Julie A. [1 ,2 ,3 ]
机构
[1] Deakin Univ, Geelong, Vic 3220, Australia
[2] Univ Melbourne, Melbourne Med Sch, Dept Med Western Hlth, St Albans, Vic 3010, Australia
[3] Barwon Hlth, Geelong, Vic 3220, Australia
基金
英国医学研究理事会;
关键词
FOLLOW-UP; CARDIOVASCULAR MORTALITY; POPULATION; ADULTS; ASSOCIATION; DIAGNOSIS; MELLITUS; FAILURE; EVENTS; BURDEN;
D O I
10.1155/2017/2042980
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims. Impaired fasting glucose (IFG) and diabetes are increasing in prevalence worldwide and lead to serious health problems. The aim of this longitudinal study was to investigate the association between impaired fasting glucose or diabetes and mortality over a 10-year period in Australian women. Methods. This study included 1167 women (ages 20-94 yr) enrolled in the Geelong Osteoporosis Study. Hazard ratios for all-cause mortality in diabetes, IFG, and normoglycaemia were calculated using a Cox proportional hazards model. Results. Women with diabetes were older and had higher measures of adiposity, LDL cholesterol, and triglycerides compared to the IFG and normoglycaemia groups (all p < 0 001). Mortality rate was greater in women with diabetes compared to both the IFG and normoglycaemia groups (HR 1.8; 95% CI 1.3-2.7). Mortality was not different in women with IFG compared to those with normoglycaemia (HR 1.0; 95% CI 0.7-1.4). Conclusions. This study reports an association between diabetes and all-cause mortality. However, no association was detected between IFG and all-cause mortality. We also showed that mortality in Australian women with diabetes continues to be elevated and women with IFG are a valuable target for prevention of premature mortality associated with diabetes.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Post-challenge glucose levels identify a high risk group for all-cause and cardiovascular mortality undetected by fasting glucose or glycated hemoglobin
    Silbernagel, G.
    Sourij, H.
    Kleber, M. E.
    Grammer, T. B.
    Winkelmann, B. R.
    Boehm, B. O.
    Marz, W.
    EUROPEAN HEART JOURNAL, 2011, 32 : 974 - 974
  • [42] The Australian mortality decline: all-cause mortality 1788-1990
    Taylor, R
    Lewis, M
    Powles, J
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 1998, 22 (01) : 27 - 36
  • [43] Impaired fasting glucose is not a risk factor for cardiovascular mortality
    Weitzman, S
    DIABETES CARE, 1999, 22 (12) : 2104 - 2104
  • [45] Glucose intolerance and all-cause mortality in Japanese migrants
    Gimeno, SGA
    Osiro, K
    Matsumura, L
    Massimino, FC
    Ferreira, SRG
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 68 (02) : 147 - 154
  • [46] Hypoglycaemia and risk of all-cause mortality in people with dementia and diabetes: a cohort study
    Mattishent, K.
    Richardson, K.
    Savva, G.
    Dhatariya, K.
    Fox, C.
    Loke, Y.
    DIABETOLOGIA, 2018, 61 : S451 - S451
  • [47] Healthy behaviours and risk of all-cause mortality
    Lahti, Jouni
    Mauramo, E.
    Lahelma, E.
    Lallukka, T.
    Pietilainen, O.
    Salmela, J.
    Salonsalmi, A.
    Rahkonen, O.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2019, 29
  • [48] Sitting Time and All-Cause Mortality Risk
    Peterson, Mark D.
    Sarma, Aruna V.
    Gordon, Paul M.
    ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (16) : 1270 - 1272
  • [49] Development and validation of an all-cause mortality risk score in type 2 diabetes
    Yang, Xilin
    So, Wing Yee
    Tong, Peter C. Y.
    Ma, Ronald C. W.
    Kong, Alice P. S.
    Lam, Christopher W. K.
    Ho, Chung Shun
    Cockram, Clive S.
    Ko, Gary T. C.
    Chow, Chun-Chung
    Wong, Vivian C. W.
    Chan, Juliana C. N.
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (05) : 451 - 457
  • [50] Type 2 Diabetes Genetic Risk and All-Cause Mortality in the United States
    Leong, Aaron
    Porneala, Bianca
    Dupuis, Josee
    Florez, Jose C.
    Meigs, James B.
    DIABETES, 2015, 64 : A40 - A40